USD 127.2
(-5.7%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 | 188.31 Million USD | 109.51% |
2023 | 89.88 Million USD | 64.54% |
2022 | 54.62 Million USD | 55.8% |
2021 | 32.11 Million USD | -24.64% |
2020 | 53.33 Million USD | 8.26% |
2019 | 42.87 Million USD | -4.66% |
2018 | 44.95 Million USD | 16.61% |
2017 | 35.23 Million USD | 23.85% |
2016 | 30.65 Million USD | 77.43% |
2015 | 17.85 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 FY | - USD | 106.97% |
2024 Q2 | 46.85 Million USD | -29.3% |
2024 Q4 | 31.23 Million USD | -32.59% |
2024 Q1 | 66.27 Million USD | 323.21% |
2024 Q3 | 46.33 Million USD | -1.1% |
2023 Q3 | 29.26 Million USD | 41.19% |
2023 FY | - USD | 59.44% |
2023 Q4 | 15.65 Million USD | -46.49% |
2023 Q1 | 27.15 Million USD | 233.59% |
2023 Q2 | 20.72 Million USD | -23.67% |
2022 Q4 | 8.45 Million USD | -46.45% |
2022 Q2 | 6.89 Million USD | -59.97% |
2022 Q1 | 17.21 Million USD | 142.83% |
2022 Q3 | 15.77 Million USD | 128.95% |
2022 FY | - USD | 55.8% |
2021 Q4 | 7.09 Million USD | -40.04% |
2021 Q3 | 11.82 Million USD | 62.5% |
2021 Q2 | 7.27 Million USD | -22.65% |
2021 FY | - USD | -24.64% |
2021 Q1 | 9.4 Million USD | 37.46% |
2020 Q4 | 6.84 Million USD | -62.49% |
2020 FY | - USD | 8.26% |
2020 Q2 | 11.46 Million USD | 7.38% |
2020 Q1 | 10.67 Million USD | -64.42% |
2020 Q3 | 18.24 Million USD | 59.13% |
2019 FY | - USD | -4.66% |
2019 Q4 | 30.01 Million USD | 137.26% |
2019 Q3 | 12.65 Million USD | 16.42% |
2019 Q2 | 10.86 Million USD | 39.54% |
2019 Q1 | 7.78 Million USD | 5.6% |
2018 Q3 | 18.32 Million USD | 41.71% |
2018 Q4 | 7.37 Million USD | -59.76% |
2018 FY | - USD | 16.61% |
2018 Q1 | 6.42 Million USD | -20.46% |
2018 Q2 | 12.93 Million USD | 101.12% |
2017 Q4 | 8.08 Million USD | -58.14% |
2017 Q2 | 1.76 Million USD | -14.58% |
2017 Q3 | 19.3 Million USD | 994.56% |
2017 Q1 | 2.06 Million USD | -83.82% |
2017 FY | - USD | 23.85% |
2016 Q1 | 4.45 Million USD | -46.22% |
2016 Q4 | 12.76 Million USD | 11.87% |
2016 FY | - USD | 77.43% |
2016 Q2 | 4.86 Million USD | 9.3% |
2016 Q3 | 11.4 Million USD | 134.52% |
2015 Q4 | 8.27 Million USD | 0.0% |
2015 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Church & Dwight Co., Inc. | 1.25 Billion USD | 85.034% |
Colgate-Palmolive Company | 4.5 Billion USD | 95.824% |
The Clorox Company | 736 Million USD | 74.414% |
Coty Inc. | 1 Billion USD | 81.246% |
The Estée Lauder Companies Inc. | 2.4 Billion USD | 92.167% |
Edgewell Personal Care Company | 285.4 Million USD | 34.018% |
Grove Collaborative Holdings, Inc. | -21.29 Million USD | 984.389% |
Hims & Hers Health, Inc. | -19.93 Million USD | 1044.493% |
Kimberly-Clark Corporation | 3.06 Billion USD | 93.86% |
Kenvue Inc. | 3.17 Billion USD | 94.069% |
Nu Skin Enterprises, Inc. | 137.65 Million USD | -36.798% |
The Procter & Gamble Company | 23.84 Billion USD | 99.21% |
Spectrum Brands Holdings, Inc. | 323.9 Million USD | 41.861% |